The Identification of Risk Factors for Chronic Chikungunya Arthralgia in Grenada, West Indies: A Cross-Sectional Cohort Study
Overview
Authors
Affiliations
Background: Chikungunya virus (CHIKV) is a re-emerging arboviral pathogen. In 2014, an explosive CHIKV outbreak occurred in Grenada, West Indies, infecting approximately 60% of the population. In approximately 50% of cases, CHIKV infection transitions to painful arthralgia that can persist for years. Elucidation of the risk factors for chronic disease is imperative to the development of effective risk management strategies and specific therapeutics.
Methods: We conducted a cross-sectional study of 240 people who were tested for CHIKV during the outbreak. We administered questionnaires to examine demographic, behavioral, psychological, social, and environmental factors to identify associations with chronic disease. Physical examinations were performed and persistent symptoms were recorded.
Results: Ethnicity and socioeconomic status were not associated with risk of chronic joint pain. Female sex increased risk, and age was demonstrated to be predictive of chronic CHIKV sequelae. Mosquito avoidance behaviors did not reduce risk. Patients suffering joint pains, generalized body ache, and weakness in the extremities during acute infection were more likely to develop chronic arthralgia, and an increased duration of acute disease also increased risk.
Conclusions: These data demonstrate that chronic CHIKV affects people across the ethnic and socioeconomic spectrum, and it is not reduced by vector avoidance activity. Increased duration of acute symptoms, in particular acute joint pain, was strongly correlated with the risk of persistent arthralgia, thus effective clinical management of acute CHIKV disease could reduce burden of chronic CHIKV.
The Chikungunya Virus nsP3 Macro Domain Inhibits Activation of the NF-κB Pathway.
Roberts G, Stonehouse N, Harris M Viruses. 2025; 17(2).
PMID: 40006946 PMC: 11861268. DOI: 10.3390/v17020191.
Lemos J, Araujo L, Guimaraes-do-Carmo V, Cardoso E, da Silva Ferreira A, Barbosa K Clin Rheumatol. 2024; 43(9):2993-3003.
PMID: 39031292 DOI: 10.1007/s10067-024-07073-5.
Long chikungunya? An overview to immunopathology of persistent arthralgia.
Silveira-Freitas J, Campagnolo M, Dos Santos Cortez M, de Melo F, Zarpelon-Schutz A, Teixeira K World J Virol. 2024; 13(2):89985.
PMID: 38984075 PMC: 11229846. DOI: 10.5501/wjv.v13.i2.89985.
Vaccine value profile for Chikungunya.
Flandes X, Hansen C, Palani S, Abbas K, Bennett C, Caro W Vaccine. 2024; 42(19S1):S9-S24.
PMID: 38407992 PMC: 11554007. DOI: 10.1016/j.vaccine.2023.07.069.
Doran C, Duits A, Gerstenbluth I, Tami A, Bailey A BMJ Open. 2024; 14(2):e076352.
PMID: 38326245 PMC: 10860096. DOI: 10.1136/bmjopen-2023-076352.